Anna Snavely to Neoplasms
This is a "connection" page, showing publications Anna Snavely has written about Neoplasms.
Connection Strength
0.423
-
Nightingale CL, Snavely AC, McLouth LE, Dressler EV, Kent EE, Adonizio CS, Danhauer SC, Cannady R, Hopkins JO, Kehn H, Weaver KE, Sterba KR. Processes for identifying caregivers and screening for caregiver and patient distress in community oncology: results from WF-1803CD. J Natl Cancer Inst. 2024 Feb 08; 116(2):324-333.
Score: 0.143
-
Lesser GJ, Irby MB, Taylor RC, Snavely A, Case D, Wang A, Dietrich A, Duncan S. Lactoferrin supplementation for taste and smell abnormalities among patients receiving cancer chemotherapy. Support Care Cancer. 2022 Mar; 30(3):2017-2025.
Score: 0.122
-
Wood WA, Krishnamurthy J, Mitin N, Torrice C, Parker JS, Snavely AC, Shea TC, Serody JS, Sharpless NE. Chemotherapy and Stem Cell Transplantation Increase p16INK4a Expression, a Biomarker of T-cell Aging. EBioMedicine. 2016 Sep; 11:227-238.
Score: 0.085
-
Boyajian RN, Grose A, Grenon N, Roper K, Sommer K, Walsh M, Snavely A, Neary S, Partridge A, Nekhlyudov L. Desired elements and timing of cancer survivorship care: one approach may not fit all. J Oncol Pract. 2014 Sep; 10(5):e293-8.
Score: 0.073